OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
© 2020 MJH Life Sciences™ and BioPharm International. All rights reserved.
August 01, 2011
Top 1000 Biomanufacturing Facilities
Achieving multiproduct development within shortened timelines.
China rises to the top as a destination for international outsourcing.
The author looks at strategies to minimize particle levels in the finished product when using single-use technologies downstream of final capabilities.
US Pharmacopeia promotes horizontal standards and a product-class approach for quality attributes.
Rising imports, overseas production spur collaboration and realignment of enforcement activities.
The authors re-examine environmental controls in the context of technical advances in manufacturing.
Industry may be its own obstacle to success in achieving the desired high-performance state.
Are biosimilars the next big thing or just the next big bubble?
Insights from real-time ranking of global biomanufacturing capabilities.